Cargando…
Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
To evaluate the response and quality of life of palliative gastric radiotherapy in patients with symptomatic locally advanced gastric cancer. Patients with bleeding, pain or obstruction and were treated with palliative gastric radiotherapy to a dose of 36 Gy in 12 daily fractions. The primary outcom...
Autores principales: | Tey, Jeremy, Zheng, Huili, Soon, Yu Y., Leong, Cheng N., Koh, Wee Y., Lim, Keith, So, Jimmy B. Y., Shabbir, Asim, Tham, Ivan W. K., Lu, Jiade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488108/ https://www.ncbi.nlm.nih.gov/pubmed/30790469 http://dx.doi.org/10.1002/cam4.2021 |
Ejemplares similares
-
Clinical Outcome of Palliative Radiotherapy for Locally Advanced Symptomatic Gastric Cancer in the Modern Era
por: Tey, Jeremy, et al.
Publicado: (2014) -
Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis
por: Tey, Jeremy, et al.
Publicado: (2017) -
Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC)
por: Yeung, Cynthia S. Y., et al.
Publicado: (2020) -
Impact of epidermal growth factor receptor sensitizing mutations on outcomes of patients with non-small cell lung cancer treated with definitive thoracic radiation therapy: a systematic review and meta-analysis
por: Soon, Yu Yang, et al.
Publicado: (2017) -
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
por: Lee, Anna, et al.
Publicado: (2021)